Form 4: CME Group Director Receives Stock Grant
Statement of Changes in Beneficial Ownership
Robert J. Tierney Jr., a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.
Summary
- Robert J. Tierney Jr., a Director of CME Group Inc., was granted 645 shares of Class A Common Stock on June 25, 2026.
- This grant is part of the company's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.
- The shares are fully vested and not subject to any further vesting conditions.
- Following this transaction, Tierney beneficially owns 14,345 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director stock grant and does not provide new financial information or strategic insights.
Positives
- Director compensation through equity awards aligns management and director interests with shareholders.
- The grant of fully vested shares indicates immediate recognition of services rendered.
- The transaction is part of a standard annual compensation program, suggesting consistent corporate practice.
Future Outlook
This filing pertains to a stock grant and does not contain forward-looking statements or guidance regarding future financial performance.
Industry Context
StockSavvy.ai notes that equity compensation for directors is a common practice across the financial services industry, including exchanges like CME Group, to incentivize long-term alignment with shareholder value.
Stakeholder Impact
- Shareholders: The equity grant aligns director interests with those of shareholders, potentially promoting long-term value creation.
- Employees: This filing is specific to director compensation and does not directly impact general employees.
Key Dates
| Date | Description |
|---|---|
| 05/06/2026 | Date of Power of Attorney for EDGAR Administration |
| 06/25/2026 | Transaction Date: Grant of Class A Common Stock |
| 06/29/2026 | Date of Signature on Form 4 |
Keywords
CME Group, Form 4, Director Compensation, Equity Award, Stock Grant, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.